These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15607829)

  • 1. The development of tolerance to locomotor effects of morphine and the effect of various opioid receptor antagonists in rats chronically treated with morphine.
    Timár J; Gyarmati Z; Fürst Z
    Brain Res Bull; 2005 Jan; 64(5):417-24. PubMed ID: 15607829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
    Le Guen S; Gestreau C; Besson JM
    Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes.
    Kamei J; Ohsawa M; Saitoh A; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
    J Pharmacol Exp Ther; 1995 Aug; 274(2):700-6. PubMed ID: 7636731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
    Funada M; Schutz CG; Shippenberg TS
    Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activation of a mutant mu-opioid receptor by naltrexone produces a potent analgesic effect but no tolerance: role of mu-receptor activation and delta-receptor blockade in morphine tolerance.
    Roy S; Guo X; Kelschenbach J; Liu Y; Loh HH
    J Neurosci; 2005 Mar; 25(12):3229-33. PubMed ID: 15788780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP[psi].
    Fundytus ME; Schiller PW; Shapiro M; Weltrowska G; Coderre TJ
    Eur J Pharmacol; 1995 Nov; 286(1):105-8. PubMed ID: 8566146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
    Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavioural studies during the gestational-lactation period in morphine treated rats].
    Sobor M; Timár J; Riba P; Király KP; Al-Khrasani M; Gyarmati Z; Fürst Z
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):239-51. PubMed ID: 24380965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
    Kelsey JE; Verhaak AM; Schierberl KC
    Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis.
    Alcaraz C; Vargas ML; Milanés MV
    Neuropeptides; 1996 Feb; 30(1):29-36. PubMed ID: 8868296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury.
    Aceves M; Bancroft EA; Aceves AR; Hook MA
    J Neurotrauma; 2017 Mar; 34(6):1164-1174. PubMed ID: 27736318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity.
    Contet C; Filliol D; Matifas A; Kieffer BL
    Neuropharmacology; 2008 Mar; 54(3):475-86. PubMed ID: 18082850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic morphine administration results in tolerance to delta opioid receptor-mediated antinociception.
    Pradhan AAA; Siau C; Constantin A; Clarke PBS
    Neuroscience; 2006 Aug; 141(2):947-954. PubMed ID: 16716526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
    Abul-Husn NS; Sutak M; Milne B; Jhamandas K
    Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
    Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
    Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Bhateja P; Singh TG; Singh N
    Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.